GGrantIndex
← Leaderboards

Jianmin Zhang

Roswell Park Cancer Institute Corp

$3,685,953
Attributed
$4,601,307
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY201425
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,601,307 · 5

By mechanism

R01$3,821,107 · 3
R21$615,325 · 1
R03$164,875 · 1

Top collaborators

Most similar at Roswell Park Cancer Institute Corp

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Breast Neoplasm

Research focus

Malignant Breast NeoplasmMolecularNeoplasm MetastasisOverexpressionSignal PathwayTriple-Negative Invasive Breast CarcinomaTumorHigh RiskIncidenceGenesCessation Of LifeMediatingCancer Stem CellCellsTumor ProgressionMouse ModelTransgenic MiceRecurrenceBreast Cancer PatientBreast Cancer ProgressionPathway InteractionsBreast Cancer CellGenome-WideInnovation

Grant awards (14)

Decipher the Molecular Mechanisms of Breast Cancer Bone Metastasis$700,690
R01 · FY2025 · CA
Dissecting Molecular Mechanisms of Tumor-Induced Myeloid-Mediated Immune Suppression in Triple-Negative Breast Cancer$558,523
R01 · FY2025 · CA · contact PI
TAZ-driven Regulation of Tumor Microenvironment in Triple-Negative Breast Cancer$78,125
R03 · FY2025 · CA · contact PI
Dissecting Molecular Mechanisms of Tumor-Induced Myeloid-Mediated Immune Suppression in Triple-Negative Breast Cancer$571,496
R01 · FY2024 · CA · contact PI
TAZ-driven Regulation of Tumor Microenvironment in Triple-Negative Breast Cancer$49,202
R03 · FY2024 · CA · contact PI
TAZ-driven Regulation of Tumor Microenvironment in Triple-Negative Breast Cancer$37,548
R03 · FY2024 · CA · contact PI
The role of TAZ in breast cancer initiation and progression$397,005
R01 · FY2021 · CA · contact PI
The role of TAZ in breast cancer initiation and progression$397,031
R01 · FY2020 · CA · contact PI
The role of TAZ in breast cancer initiation and progression$385,157
R01 · FY2019 · CA · contact PI
The role of TAZ in breast cancer initiation and progression$405,084
R01 · FY2018 · CA · contact PI
The role of TAZ in breast cancer initiation and progression$406,121
R01 · FY2017 · CA · contact PI
Hippo signaling pathway in breast cancer disparities: a translational approach$229,028
R21 · FY2015 · CA · contact PI
Hippo signaling pathway in breast cancer disparities: a translational approach$195,441
R21 · FY2015 · CA · contact PI
Hippo signaling pathway in breast cancer disparities: a translational approach$190,856
R21 · FY2014 · CA · contact PI